Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma Therapy for MERS-CoV
NCT02190799Phase 2Withdrawn
- Sponsor
- King Abdullah International Medical Research Center
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in Middle East respiratory syndrome (MERS), sponsored by King Abdullah International Medical Research Center. Planned start May 2014; status: withdrawn.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
Middle East respiratory syndrome (MERS)
Beyond the preview
Go deeper on NCT02190799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02190799.